课题基金 / 基金详情

INDUCTION OF HIV 1 REPLICATION IN LATENTLY INFECTED CD4+ T CELLS

INDUCTION OF HIV 1 REPLICATION IN LATENTLY INFECTED CD4+ T CELLS
在潜伏感染的 CD4 T 细胞中诱导 HIV 1 复制
批准号:
6099135
负责人:
T CHUN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

T CHUN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Certain cytokines, particularly pro-inflammatory cytokines, can enhance ongoing viral replication in peripheral blood mononuclear cells (PBMCs) of HIV-1 infected individuals; however, it is unclear what role these cytokines play in the induction of HIV-1 replication in latently infected, resting CD4+ T cells. Our study demonstrates that the in vitro combination of the pro-inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha together with the immunoregulatory cytokine IL-2 are potent inducers of viral replication in highly purified, latently infected, resting CD4+ T cells derived from HIV-infected individuals who are antiretroviral therapy naive as well as those who are receiving highly active antiretroviral therapy (HAART). Viral replication induced by this combination of cytokines was completely suppressed in the presence of HAART in vitro. Given that an array of cytokines, including IL-6, TNF-alpha and IL-2 are copiously expressed in the microenvironment of the lymphoid tissues, which harbor the latent viral reservoirs, induction of HIV by this combination of cytokines may in part explain the commonly observed reappearance of detectable plasma viremia in HIV-infected individuals in whom HAART was discontinued. Moreover, since it is likely that these infected cells die upon activation of virus and that HAART prevents spread of virus to adjacent cells, the observation that this combination of cytokines can markedly induce viral replication in this reservoir may have important implications for the activation- mediated diminution of the latent reservoir of HIV in patients receiving HAART.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
EARLY ESTABLISHMENT OF HIV 1 LATENCY IN RESTING CD4+ T CELLS
海外基金